Sharing Life Sciences Innovations
Closing the gender gap in biotech funding: a follow-up study
In this follow-up to a previous VC Views article, V-Bio Ventures takes a look at several questions that were generated by readers. The VC firm carried out a study of the gender composition of inve…
Pulsify Medical, a joint imec and KU Leuven spin-off, closes first-round funding, led by imec.xpand
Pulsify Medical will develop wearable ultrasound patches for non-invasive, real time monitoring of physiological parameters inside the body Leuven, Belgium, 12 October, 2019. Pulsify Medical, …
HIV breakthrough at UZ Gent leads to new hope for a cure
When patients take HIV medication, a small amount of the virus nonetheless stays hidden in the body, preventing a cure. This hiding place has finally been uncovered in a groundbreaking study led b…
Three business strategy tips to help your company grow
Turnstone Communications, the driving force behind BioVox news, is a consultancy agency catering to life sciences companies. Lending a hand with communications, marketing and business development,…
Fresh insights into the future of cell therapy
The first edition of Science for health was held in the heart of Brussels on September 11 with a focus on cell therapy. The event attracted over 300 researchers, clinicians and industry profession…
Galapagos-Gilead billion-dollar deal: beyond the numbers
Last month, Galapagos sealed a 5-billion-dollar deal with Gilead. Now that the dust has started to settle, we’re taking a closer look at the agreement. Why is this deal so unique in the biotech wo…
Why events are important for creating connections in the life sciences
Collaboration is vital for science. Without cross-pollination of ideas and talent, progress would be excruciatingly slow in both industry and academia. Networking opportunities, like the annual Kn…
How do we reduce the high cost of clinical trials?
Drug development is an exorbitantly expensive endeavor. A large expense factor for developing a new therapy is the high cost of conducting clinical trials. Why are clinical trials so insanely expe…
Gilead and Galapagos enter into transformative research and development collaboration
Gilead to Make $3.95 Billion Upfront Payment and $1.1 Billion Equity Investment Gilead Gains Access to Galapagos’ Differentiated Drug Discovery Platform and Current and Future Pipeline O…
Confo Therapeutics and DyNAbind announce drug discovery collaboration to identify novel GPCR-modulating compounds
Ghent, Belgium, and Dresden, Germany - 3 July 2019 – Confo Therapeutics, an emerging drug discovery company, and DyNAbind GmbH today announce a drug discovery collaboration on an undisclosed G-pro…
Join our mailing list and receive the monthly BioVox newsletter for free!
Upcoming events
CRIG Industrial partnering event 2019
Auditorium 4
Sint-Denijslaan 485
9000 Gent
Belgium
Fri 25 Oct 2019
08:00
The Cancer Research Institute Ghent (CRIG) welcomes you to its 2nd industrial partnering event! We are pleased to announce the 2nd edition of the Cancer Research Institute Ghent (CRIG) industr…
BCF Career Event Belgium 2019
Ghent ICC, Belgium
Thu 14 Nov 2019
09:00
BCF Career Event is the largest Belgian career event for the Life Sciences. It is the meeting place for everyone who is or wants to be active in Bio/Life Sciences, Chemistry, Food or Pharma. BCF C…
3Rs symposium and workshop 2019
Life Science campus, Building A and Basic Fit
Vrije Universiteit Brussel
Laarbeeklaan 103
1090 Brussel
BELGIUM
Thu 21 Nov 2019 - Fri 22 Nov 2019
21 Nov 09:00
- 22 Nov 16:00
“Innovative tools for 3Rs testing” symposium & “Designing a research project according to the 3Rs” workshop This year the annual meeting of BelTox will be organized as a joint event together w…
